What is the Supha Pharmachem Ltd share price today?

The share price of BSE:SUPHA-Z on 01 Oct 2026 (as of 15:06:58 IST) is ₹0.27.

What is the BSE:SUPHA-Z 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the BSE:SUPHA-Z 52 week high low range shows a high of ₹1.8 and a low of ₹0.25.

What is the Supha Pharmachem Ltd market cap?

As on 01 Oct 2026, Supha Pharmachem Ltd market cap is ₹238137000.

What is the shareholding pattern of Supha Pharmachem Ltd Stock?

The shareholding pattern of Supha Pharmachem Ltd, as of last reported-on 31 Dec 2025 is: Promoters: 1.13% Foreign Institutional Investors (FII): 1.7% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 97.17% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Supha Pharmachem Ltd?

The Price-to-Earnings (PE) ratio of Supha Pharmachem Ltd is 11.1833, and the Price-to-Book (PB) ratio is 1.6719, as on 01 Oct 2026.

Supha Pharmachem Share Price

0.25+0.01 (+4.17%)

-83.97% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+4.17%

1 Week

+4.17%

1 Month

-3.85%

3 Month

-24.24%

6 Month

-43.18%

YTD

-66.67%

1 Year

-83.97%

5 Year

-88.14%

10 Year

NA

Max

-41.58%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

0.23

High

0.25

0.27

0.34

0.42

1.66

About

Remedium Lifecare Ltd. (formerly known as Roxy Exports Limited) is pharmaceutical company aligned across two business verticals viz. Products and Services. Its Products business comprises manufacture and sale of APIs Read more

Trading

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

ADANIENT-ANSE

CPPLUS-ANSE

PREMIERENE-ANSE

AEGISLOG-ANSE

REDINGTON-ANSE

HONASA-ANSE

LLOYDSENT-ANSE

CELLO-ANSE

JSLL-ANSE

SREEL-TNSE

SUPHA-ZNSE

LTP

1W Low

1W High

Market cap (₹)

2590-17.5 (-0.67%)

2559

2634

3,53,335Cr

3890-61.15 (-1.55%)

3624.65

3947.90

47,150Cr

888.9+26.9 (3.12%)

850

894

40,334Cr

1180.25-0.6 (-0.05%)

1082

1253.90

38,645Cr

335.35-21.6 (-6.05%)

315

356.75

25,810Cr

456+8.1 (1.81%)

435.40

465.55

14,727Cr

60.57-2.14 (-3.41%)

59.72

62.86

9,182Cr

341.7-0.8 (-0.23%)

326.05

353.95

7,800Cr

343-4.7 (-1.35%)

330.20

350.05

4,225Cr

264.2+10.2 (4.02%)

248.40

271.50

607Cr

0.25+0.01 (4.17%)

0.23

0.25

21Cr

Supha Pharmachem Share Price

0.25+0.01 (+4.17%)

-83.97% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Supha Pharmachem Share Price

0.25+0.01 (+4.17%)

-83.97% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year0%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year0%

Stock Price CAGR

10 years-

5 years-34%

3 years-83%

1 year-83%

Return on Equity

10 years5%

5 years5%

3 years5%

Last year5%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	0%
-	-	-	0%
-	-34%	-83%	-83%
5%	5%	5%	5%

Peer Comparison

Symbol

ADANIENT-A

CPPLUS-A

PREMIERENE-A

AEGISLOG-A

REDINGTON-A

HONASA-A

LLOYDSENT-A

CELLO-A

JSLL-A

SREEL-T

SUPHA-Z

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
2,590	₹353335 Cr	61.58	11.02	97.19	₹9339 Cr
3,890	₹47150 Cr	98.79	12.07	43.68	₹368 Cr
888.9	₹40334 Cr	24.22	10.2	45.28	₹1510 Cr
1,180.25	₹38645 Cr	29.01	7.42	44.04	₹898 Cr
335.35	₹25810 Cr	15.17	6.22	24.36	₹1490 Cr
456	₹14727 Cr	59.17	2.77	8.99	₹200 Cr
60.57	₹9182 Cr	81.77	0.38	0.91	₹283 Cr
341.7	₹7800 Cr	24.93	3.32	17.46	₹332 Cr
343	₹4225 Cr	17.87	5.31	23.32	₹222 Cr
264.2	₹607 Cr	18.5	3.02	14.74	₹29 Cr
0.25	₹21 Cr	9.94	0.1	0.02	₹2 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2025	Jun 2025	Mar 2025
₹111 Cr	₹113 Cr	₹264 Cr
₹3 Cr	₹3 Cr	₹66 L
₹114 Cr	₹117 Cr	₹265 Cr
₹104 Cr	₹111 Cr	₹265 Cr
₹11 Cr	₹5 Cr	₹20 L
₹19 L	-₹37 L	₹2 Cr
₹10 Cr	₹6 Cr	-₹1 Cr
₹9 Cr	₹5 Cr	-₹2 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Deferred Tax Assets / Liabilities

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2025
—
₹40 Cr
₹4 Cr
₹4 Cr
₹44 Cr
-₹4 L
-₹4 L
—
₹501 Cr
₹32 Cr
₹1141 Cr
₹2 Cr
₹1676 Cr
₹1720 Cr
₹1141 Cr
—
₹22 L
₹22 L
₹83,000
₹83,000
—
₹269 Cr
₹772 Cr
₹1 Cr
₹3 Cr
₹675 Cr
₹1720 Cr
₹44 Cr
₹1720 Cr
₹1
₹1

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Closing Cash & Cash Equivalent

Mar 2025
₹4 Cr
₹5 Cr
-₹1144 Cr
-₹1135 Cr
-₹1135 Cr
₹13 L
₹1136 Cr
₹1 Cr
₹1 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Supha Pharmachem Share Price

0.25+0.01 (+4.17%)

-83.97% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Supha Pharmachem Share Price

0.25+0.01 (+4.17%)

-83.97% past 1 Year

Shareholding summary

Promoters

1.13%

FII

1.7%

DII

0%

MF

0%

Others

97.17%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
1.13%	1.13%	1.13%	1.11%	1.11%	1.11%
1.70%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
97.17%	98.87%	98.87%	98.89%	98.89%	98.89%

Bulk & block deals

Name

Mahalaxmi Brokerage (India) Private Limited

Prakash Anand Gupta

Rg Traders

Aakashhiteshbhaizinzuvadia

Rg Traders

L7 Hitech Private Limited

Ishaan Tradefin Llp

Share India Securities Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
23 Oct 2026	Sell	12 L	₹0.24	50 L	Bulk	0.5669	BSE
17 Jun 2026	Sell	17.58 L	₹0.27	65.10 L	Bulk	0.738151	BSE
07 Apr 2026	Sell	15.15 L	₹0.34	44.56 L	Bulk	0.505169	BSE
30 Mar 2026	Sell	18.19 L	₹0.32	56.85 L	Bulk	0.644565	BSE
30 Mar 2026	Purchase	23.69 L	₹0.32	74.02 L	Bulk	0.839249	BSE
18 Mar 2026	Sell	29.79 L	₹0.39	76.38 L	Bulk	0.865968	BSE
12 Mar 2026	Sell	27.32 L	₹0.46	59.39 L	Bulk	0.673364	BSE
12 Mar 2026	Purchase	4.23 L	₹0.45	9.39 L	Bulk	0.106464	BSE
12 Mar 2026	Purchase	44.02 L	₹0.47	93.67 L	Bulk	1.062016	BSE
12 Mar 2026	Sell	41.69 L	₹0.46	90.64 L	Bulk	1.027677	BSE

Insider trading & SAST

Client name

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type

Supha Pharmachem Share Price

0.25+0.01 (+4.17%)

-83.97% past 1 Year

Remedium Lifecare Ltd. (formerly known as Roxy Exports Limited) is pharmaceutical company aligned across two business verticals viz. Products and Services. Its Products business comprises manufacture and sale of APIs

Corporate Actions

Date

Type

Details

2025-04-15

Rights

61:50;0

2024-07-05

Bonus

3:1

2024-02-23

Split

5:1

2023-09-01

Split

10:5

2023-07-28

Bonus

9:5

Company details

Registered office

Office No. F 81 D, Express Zone Mall A Wing Next To Patel Vanika W. E. Highway Goregaon (East) Mumbai Maharashtra PIN: 400063 Tel No: 8433895251 Fax No: NULL Email: [email protected] Internet: www.remlife.com

Registrars

Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093(old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: Office No S6-2, 6th Floor, Pinnacle Business Park Next to Ahura Centre, Mahakali Caves Road Andheri (E) PIN: Tel No: 91-022-62638200 Fax No: 91-022-62638299 Email: [email protected]

Management

Adarsh Munjal, Whole Time Director

Dipesh Vaidya, Non Executive Independent Director

Vijay Pal, Non Executive Independent Director

Bikram Kumar Mund, Non Executive Independent Director

Shamim Adil Michal, Non Executive Independent Director

Vignesh Laxman Gawde, Executive Director

Rambhajan Vishwakarma, Chairman

Details

BSE 539561

NSE NULL

ISIN INE549S01036